Tag: CMS

Judge Axes Price Disclosure Rule for Drug Ads

The Trump administration cannot force drug manufacturers to disclose prices in their pharmaceutical ads to consumers, a federal judge ruled Monday....

CMS Posts Agenda for June 24 CLFS Annual Public Meeting

On June 7, CMS posted the agenda for the annual public CLFS meeting. On June 7, 2019, the Centers for Medicare and Medicaid Services released the at-a-glance agenda for their Clinical Laboratory Fee Schedule (CLFS) annual public meeting on June, 2...

CMS Releases Final Part D Rule

On May 16, 2018, CMS released the final Part D and Medicare Advantage rule aimed at lowering drug prices. On May 16, 2018, the Centers for Medicare and Medicaid Services (CMS) released the final Part D and Medicare Advantage (MA) rule aimed at low...

CMS Issues Pair of Rules on Line Item Extension Drugs

CMS issues pair of final rules addressing line item extension drugs. The Centers for Medicare and Medicaid Services (CMS) has issued an interim final rule revising the calculation of rebates for line item extension drugs and a final rule declining...

CMS Updates Drug Spending Dashboards

CMS updated its drug spending dashboards with data for 2017. The Centers for Medicare and Medicaid Services (CMS) updated its drug spending dashboards with data for 2017. The dashboards show average spending per dosage unit for prescription drugs...

Members Send Letter to HHS Opposing Changes to Protected Classes

On March 13, 2019, more than 70 members joined Representatives Barbara Lee (D-CA) and Will Hurd (R-TX) in sending a letter to Secretary and of Health and Human Services Alex Azar expressing opposition to the CMS proposed rule changing the six protect...

Medicare Prescription Drug Price Negotiation Act of 2019

On January 8, 2019, Representative Peter Welch (D-VT) introduced legislation (H.R. 275) allowing Medicare to negotiate lower drug prices in the Part D program.   Read the full article here....

Regulation to Require Drug Pricing Transparency

...